These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15941854)

  • 1. Clonal heterogeneity in growth kinetics of CD34+CD38- human cord blood cells in vitro is correlated with gene expression pattern and telomere length.
    Bartolović K; Balabanov S; Berner B; Bühring HJ; Komor M; Becker S; Hoelzer D; Kanz L; Hofmann WK; Brümmendorf TH
    Stem Cells; 2005 Aug; 23(7):946-57. PubMed ID: 15941854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microarray and serial analysis of gene expression analyses identify known and novel transcripts overexpressed in hematopoietic stem cells.
    Georgantas RW; Tanadve V; Malehorn M; Heimfeld S; Chen C; Carr L; Martinez-Murillo F; Riggins G; Kowalski J; Civin CI
    Cancer Res; 2004 Jul; 64(13):4434-41. PubMed ID: 15231652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive amplification of single cells from CD34+ subpopulations in umbilical cord blood and identification of long-term culture-initiating cells present in two subsets.
    de Wynter EA; Nadali G; Coutinho LH; Testa NG
    Stem Cells; 1996 Sep; 14(5):566-76. PubMed ID: 8888497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analyses to clarify rich fractions in hepatic progenitor cells from human umbilical cord blood and cell fusion.
    Tanabe Y; Tajima F; Nakamura Y; Shibasaki E; Wakejima M; Shimomura T; Murai R; Murawaki Y; Hashiguchi K; Kanbe T; Saeki T; Ichiba M; Yoshida Y; Mitsunari M; Yoshida S; Miake J; Yamamoto Y; Nagata N; Harada T; Kurimasa A; Hisatome I; Terakawa N; Murawaki Y; Shiota G
    Biochem Biophys Res Commun; 2004 Nov; 324(2):711-8. PubMed ID: 15474486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD34++ CD38- and CD34+ CD38+ human hematopoietic progenitors from fetal liver, cord blood, and adult bone marrow respond differently to hematopoietic cytokines depending on the ontogenic source.
    Weekx SF; Van Bockstaele DR; Plum J; Moulijn A; Rodrigus I; Lardon F; De Smedt M; Nijs G; Lenjou M; Loquet P; Berneman ZN; Snoeck HW
    Exp Hematol; 1998 Oct; 26(11):1034-42. PubMed ID: 9766443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
    Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine expansion culture of cord blood CD34+ cells induces marked and sustained changes in adhesion receptor and CXCR4 expressions.
    Denning-Kendall P; Singha S; Bradley B; Hows J
    Stem Cells; 2003; 21(1):61-70. PubMed ID: 12529552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly efficient lentiviral gene transfer in CD34+ and CD34+/38-/lin- cells from mobilized peripheral blood after cytokine prestimulation.
    Géronimi F; Richard E; Redonnet-Vernhet I; Lamrissi-Garcia I; Lalanne M; Ged C; Moreau-Gaudry F; De Verneuil H
    Stem Cells; 2003; 21(4):472-80. PubMed ID: 12832700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CD34(+)CD38(neg) population is significantly increased in haemopoietic cell expansion cultures in serum-free compared to serum-replete conditions: dissociation of phenotype and function.
    Donaldson C; Denning-Kendall P; Bradley B; Hows J
    Bone Marrow Transplant; 2001 Feb; 27(4):365-71. PubMed ID: 11313665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic and functional analyses of CD34NEG hematopoietic precursors from mobilized peripheral blood.
    Dooley DC; Oppenlander BK
    Methods Mol Biol; 2004; 263():201-18. PubMed ID: 14976368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Karyotyping, immunophenotyping, and apoptosis analyses on human hematopoietic precursor cells derived from umbilical cord blood following long-term ex vivo expansion.
    Tian H; Huang S; Gong F; Tian L; Chen Z
    Cancer Genet Cytogenet; 2005 Feb; 157(1):33-6. PubMed ID: 15676144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential expression of the vasoactive intestinal peptide (VIP) receptor VPAC1 in human cord blood-derived CD34+CD38- cells: possible role of VIP as a growth-promoting factor for hematopoietic stem/progenitor cells.
    Kawakami M; Kimura T; Kishimoto Y; Tatekawa T; Baba Y; Nishizaki T; Matsuzaki N; Taniguchi Y; Yoshihara S; Ikegame K; Shirakata T; Nishida S; Masuda T; Hosen N; Tsuboi A; Oji Y; Oka Y; Ogawa H; Sonoda Y; Sugiyama H; Kawase I; Soma T
    Leukemia; 2004 May; 18(5):912-21. PubMed ID: 14999295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo expansion of stem cells from umbilical cord blood: expression of cell adhesion molecules.
    Dravid G; Rao SG
    Stem Cells; 2002; 20(2):183-9. PubMed ID: 11897875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique biological properties and application potentials of CD34+ CD38- stem cells from various sources.
    Wang TY; Chang SJ; Chang MD; Wang HW
    Taiwan J Obstet Gynecol; 2009 Dec; 48(4):356-69. PubMed ID: 20045756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A human stromal-based serum-free culture system supports the ex vivo expansion/maintenance of bone marrow and cord blood hematopoietic stem/progenitor cells.
    da Silva CL; Gonçalves R; Crapnell KB; Cabral JM; Zanjani ED; Almeida-Porada G
    Exp Hematol; 2005 Jul; 33(7):828-35. PubMed ID: 15963859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of CD34+ subsets derived from bone marrow, umbilical cord blood and mobilized peripheral blood after stem cell factor and interleukin 3 stimulation.
    De Bruyn C; Delforge A; Lagneaux L; Bron D
    Bone Marrow Transplant; 2000 Feb; 25(4):377-83. PubMed ID: 10723580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Growth properties of hematopoietic stem/progenitor cells in the second or third trimester and term fetal cord blood].
    Ma Y; Zou P; Xiao J; Huang S
    Zhonghua Yi Xue Za Zhi; 2002 Mar; 82(5):330-3. PubMed ID: 11953192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparameter-fluorescence activated cell sorting analysis of retroviral vector gene transfer into primitive umbilical cord blood cells.
    McCowage GB; Phillips KL; Gentry TL; Hull S; Kurtzberg J; Gilboa E; Smith C
    Exp Hematol; 1998 Apr; 26(4):288-98. PubMed ID: 9546311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High efficiency electroporation of human umbilical cord blood CD34+ hematopoietic precursor cells.
    Wu MH; Smith SL; Dolan ME
    Stem Cells; 2001; 19(6):492-9. PubMed ID: 11713340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells.
    Luck L; Zeng L; Hiti AL; Weinberg KI; Malik P
    Exp Hematol; 2004 May; 32(5):483-93. PubMed ID: 15145217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.